Lanean...
PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates
PF-05231023, a long-acting FGF21 analogue, is a promising potential pharmacotherapy for the treatment of obesity and associated comorbidities. Previous studies have shown the potential of FGF21 and FGF21-like compounds to decrease body weight in mice, non-human primates, and humans; the precise mech...
Gorde:
| Argitaratua izan da: | J Pharmacokinet Pharmacodyn |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer US
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4954843/ https://ncbi.nlm.nih.gov/pubmed/27405817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10928-016-9481-1 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|